Overview
Genetic posterior fossa malformation (Orphanet code 269557) is a broad grouping term that encompasses a heterogeneous collection of rare congenital brain malformations affecting structures within the posterior fossa, which contains the cerebellum, brainstem, and fourth ventricle. These malformations arise from disruptions in the normal embryological development of posterior fossa structures and have an identifiable genetic basis, distinguishing them from acquired or purely sporadic forms. Specific conditions within this category include Dandy-Walker malformation, Joubert syndrome, rhombencephalosynapsis, cerebellar hypoplasia, and various pontocerebellar hypoplasias, among others. Clinical features vary widely depending on the specific malformation but commonly include motor developmental delay, hypotonia, ataxia (impaired coordination), intellectual disability, abnormal eye movements (such as oculomotor apraxia), and breathing irregularities in neonates. Hydrocephalus may develop due to obstruction of cerebrospinal fluid flow. Some forms are associated with additional systemic involvement including renal cysts, hepatic fibrosis, retinal dystrophy, or skeletal anomalies, particularly in ciliopathy-related conditions such as Joubert syndrome and related disorders. Because this is a classification group rather than a single disease entity, the genetic basis is highly variable, involving numerous genes with autosomal recessive, autosomal dominant, or X-linked inheritance patterns depending on the specific condition. Diagnosis typically relies on brain MRI demonstrating characteristic posterior fossa abnormalities, combined with genetic testing (exome or genome sequencing, gene panels). Treatment is supportive and symptom-directed, including neurosurgical intervention for hydrocephalus, physical and occupational therapy for motor impairments, speech therapy, and management of associated organ involvement. No curative therapies currently exist for the underlying genetic causes.
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Genetic posterior fossa malformation.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Genetic posterior fossa malformation at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Genetic posterior fossa malformation.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Genetic posterior fossa malformation.
Community
No community posts yet. Be the first to share your experience with Genetic posterior fossa malformation.
Start the conversation →Latest news about Genetic posterior fossa malformation
No recent news articles for Genetic posterior fossa malformation.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Genetic posterior fossa malformation
What is Genetic posterior fossa malformation?
Genetic posterior fossa malformation (Orphanet code 269557) is a broad grouping term that encompasses a heterogeneous collection of rare congenital brain malformations affecting structures within the posterior fossa, which contains the cerebellum, brainstem, and fourth ventricle. These malformations arise from disruptions in the normal embryological development of posterior fossa structures and have an identifiable genetic basis, distinguishing them from acquired or purely sporadic forms. Specific conditions within this category include Dandy-Walker malformation, Joubert syndrome, rhombencepha
At what age does Genetic posterior fossa malformation typically begin?
Typical onset of Genetic posterior fossa malformation is neonatal. Age of onset can vary across affected individuals.